サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1561552

オピオイド市場レポート：製品タイプ、用途、流通チャネル、地域別、2024年～2032年

Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 145 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
オピオイド市場レポート：製品タイプ、用途、流通チャネル、地域別、2024年～2032年
出版日: 2024年09月10日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のオピオイド市場の市場規模は2023年に219億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて2.8%の成長率（CAGR）を示し、2032年には283億米ドルに達すると予測しています。慢性疼痛疾患の罹患率の上昇、高齢者人口の増加、がん診断の増加、ヘルスケアサービスへのアクセス改善、研究開発への継続的な取り組み、消費者意識の高まり、有利な政府規制などが市場を推進する主な要因です。

オピオイド市場分析：

  • 主な市場促進要因：オピオイド市場の分析では、慢性疼痛、高齢者人口の増加、関節炎やがんを含む疾患の有病率の増加などの重要な要因が特定されています。
  • 主要市場動向：オピオイド市場予測に基づく主要動向には、中毒リスクを最小化するためのオピオイドの乱用抑止剤（ADF）開発への継続的なシフトが含まれます。
  • 地理的動向：オピオイド市場は、処方率の高さ、整備されたヘルスケアシステム、慢性疼痛人口の多さなどから北米が支配的です。その他の地域も、医療費の増加、疼痛管理の選択肢に対する認識、インフラの拡充により成長を遂げています。
  • 競合情勢：オピオイド業界の主要市場プレイヤーには、ベーリンガー・インゲルハイム・インターナショナルGmbH、ヒクマ・ファーマシューティカルズPLC、マリンクロットPLC、ファイザーInc.、パデュー・ファーマL.P.、サノフィS.A.、サン・ファーマシューティカル・インダストリーズLtd.、テバ・ファーマシューティカル・インダストリーズLtd.などがいます。
  • 課題と機会：オピオイド市場は、規制強化や非オピオイド疼痛管理オプションへの需要増加といった課題に直面しています。しかし、効果的で乱用や中毒を引き起こしにくい新しいオピオイド製剤を開発し、市場に投入するチャンスもあります。

オピオイド市場動向

慢性疼痛の増加

世界中で慢性疼痛が増加していることが、オピオイド産業成長の主な要因です。2021年には、米国成人の20.9％以上（5,160万人）が慢性疼痛に苦しんでおり、6.9％（1,710万人）が影響の大きい慢性疼痛（i.e.日常活動を著しく制限する疼痛）を訴えています。何百万人もの人々が、関節炎、腰痛、神経障害などの病気によって一般的に引き起こされる慢性疼痛に苦しんでおり、効果的な疼痛管理治療の利用を後押ししています。米国疾病予防管理センター（CDC）によると、2019年から2021年にかけて、米国では約5,320万人（21.2％）が医師から関節炎と診断されました。その結果、オピオイドは激痛の治療に有効であるため、ヘルスケア開業医によって処方されています。

高齢人口の増加

オピオイド業界を牽引しているのは、老年人口の増加です。2022年、65歳以上の人口は7億7,100万人で、世界人口の約10％を占める。2022年には、インドで14.9億人が60歳以上と記録され、総人口の約10.5%を占める。また、欧州連合（EU）の人口は2023年に4億4,880万人になり、その5分の1以上（21.3％）が65歳以上になると予測されています。高齢者は、退行性関節疾患やがんなどの加齢に関連した疾患により、慢性的な痛みに耐える可能性が高いです。そのため、疼痛治療の選択肢に対するニーズが高まっています。米国では65歳以上の成人のうち、47％が関節炎と診断されていると推定されています。また、変形性関節症は2番目に多いリウマチ性問題であり、インドでは22％から39％の有病率で、最も頻度の高い関節疾患です。ほぼ、65歳以上の女性の45％に症状があり、65歳以上の70％にX線学的証拠が見られます。

世界中で増加するがん罹患率

特に新興国でのがん診断率の増加が、オピオイドの需要に拍車をかけています。国際がん研究機関（IARC）は、2022年には新たに2,000万人のがん患者が発生し、970万人が死亡すると推定しています。また、がんと診断されてから5年後に生存している人の数は5,350万人と予想されています。さらに、約5人に1人が一生の間にがんに罹患し、男性の9人に1人、女性の12人に1人ががんで死亡しています。がん患者はしばしば大きな痛みを経験し、オピオイドはがん疼痛治療の重要な要素となっています。国際的にがん罹患率が増加するにつれ、効果的な疼痛管理の需要も増加し、オピオイド産業の拡大を牽引しています。

本レポートで扱う主な質問

  • 世界のオピオイド市場はこれまでどのように推移してきたか？
  • 世界のオピオイド市場における促進要因、抑制要因、機会は何か？
  • 各駆動要因、抑制要因、機会が世界のオピオイド市場に与える影響は？
  • 主要な地域市場とは？
  • 最も魅力的なオピオイド市場はどの国か？
  • 製品タイプ別の市場内訳は？
  • オピオイド市場で最も魅力的な製品タイプは？
  • 用途別の市場内訳は？
  • オピオイド市場で最も魅力的な用途は？
  • 流通チャネル別の市場内訳は？
  • オピオイド市場で最も魅力的な流通チャネルは？
  • 市場の競合構造は？
  • 世界のオピオイド市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のオピオイド市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • コデイン
    • 市場動向
    • 市場予測
  • フェンタニル
    • 市場動向
    • 市場予測
  • メサドン
    • 市場動向
    • 市場予測
  • オキシコドン
    • 市場動向
    • 市場予測
  • モルヒネ
    • 市場動向
    • 市場予測
  • ヒドロコドン
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 疼痛管理
    • 市場動向
    • 市場予測
  • 咳の治療
    • 市場動向
    • 市場予測
  • 下痢の治療
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：流通チャネル別

  • 病院薬局
    • 市場動向
    • 市場予測
  • 小売薬局
    • 市場動向
    • 市場予測
  • ドラッグストア
    • 市場動向
    • 市場予測
  • オンラインストア
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Boehringer Ingelheim International GmbH
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt plc
    • Pfizer Inc.
    • Purdue Pharma L.P.
    • Sanofi S.A.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
図表

List of Figures

  • Figure 1: Global: Opioids Market: Major Drivers and Challenges
  • Figure 2: Global: Opioids Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Opioids Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Opioids Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Opioids Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Opioids Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Opioids Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Opioids (Codeine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Opioids (Codeine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Opioids (Fentanyl) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Opioids (Fentanyl) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Opioids (Methadone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Opioids (Methadone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Opioids (Oxycodone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Opioids (Oxycodone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Opioids (Morphine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Opioids (Morphine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Opioids (Hydrocodone) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Opioids (Hydrocodone) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Opioids (Pain Management) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Opioids (Pain Management) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Opioids (Cough Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Opioids (Cough Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Opioids (Diarrhea Treatment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Opioids (Diarrhea Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Opioids (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Opioids (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Opioids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Opioids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Opioids (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Opioids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Opioids (Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Opioids (Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Opioids (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Opioids (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Opioids (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Opioids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia-Pacific: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia-Pacific: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Opioids Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Opioids Market: Breakup by Country (in %), 2023
  • Figure 86: Middle East and Africa: Opioids Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Global: Opioids Industry: SWOT Analysis
  • Figure 88: Global: Opioids Industry: Value Chain Analysis
  • Figure 89: Global: Opioids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Opioids Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Opioids Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Opioids Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Opioids Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Opioids Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Opioids Market: Competitive Structure
  • Table 7: Global: Opioids Market: Key Players
目次
Product Code: SR112024A4559

The global opioids market size reached US$ 21.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.3 Billion by 2032, exhibiting a growth rate (CAGR) of 2.8% during 2024-2032. The rising incidence of chronic pain conditions, increasing elderly population, increase in cancer diagnoses, improved access to healthcare services, ongoing research and development (R&D) efforts, escalating consumer awareness, and favorable government regulations are some of the major factors propelling the market.

Opioids Market Analysis:

  • Major Market Drivers: The opioid market analysis identifies important factors, such as chronic pain, growing elderly population, and increasing prevalence of diseases including arthritis and cancer.
  • Key Market Trends: Based on the opioid market forecast, the major trends include the ongoing shift towards the development of abuse-deterrent formulations (ADF) of opioids to minimize the risk of addiction.
  • Geographical Trends: The opioid market is dominated by North America due to high prescription rates, a well-established healthcare system, and the prevalence of chronic pain conditions among its population. Other regions are also experiencing growth due to increased healthcare expenditure, awareness of pain management options, and infrastructure expansion.
  • Competitive Landscape: Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd., among many others.
  • Challenges and Opportunities: The opioid market faces challenges, such as stricter regulatory controls and increased demand for non-opioid pain management options. However, there is an opportunity to develop and market new opioid formulations that are effective and less likely to lead to abuse and addiction.

Opioids Market Trends:

Increasing prevalence of chronic pain

The increasing incidence of chronic pain throughout the world is a primary driver of opioid industry growth. In 2021, over 20.9% of U.S. adults (51.6 million) suffered chronic pain, while 6.9% (17.1 million) reported high-impact chronic pain (i.e., pain that significantly limits daily activities). Millions of people suffer from chronic pain, which is commonly caused by ailments, such as arthritis, back difficulties, or neuropathic disorders, boosting the use of effective pain management treatments. In 2019-2021, around 53.2 million US individuals (21.2%) had arthritis diagnosed by a doctor, according to the Center for Disease Control and Prevention (CDC). As a result, opioids are prescribed by healthcare practitioners because of their effectiveness in treating severe pain.

Growing geriatric population

The opioids industry is driven by the growing geriatric population. In 2022, there were 771 million persons aged 65 and over, accounting for about 10% of the global population. In 2022, 14.9 crore people in India were recorded to be 60 years or older, accounting for approximately 10.5% of the total population. In addition, the population of the European Union (EU) was predicted to be 448.8 million in 2023, with more than one-fifth (21.3%) of it aged 65 and more. Geriatric individuals are more likely to endure chronic pain due to age-related disorders, such as degenerative joint disease and cancer. This has raised the need for pain treatment choices. It is estimated that among adults aged 65 and older, 47% are diagnosed with arthritis in the USA. Also, osteoarthritis is the second most common rheumatologic problem, and it is the most frequent joint disease with a prevalence of 22% to 39% in India. Nearly, 45% of women over the age of 65 years have symptoms while radiological evidence is found in 70% of those over 65 years.

Rising cancer rates across the globe

The increasing rate of cancer diagnoses, particularly in emerging nations, is fueling the demand for opioids. The International Agency for Research on Cancer (IARC) estimated that 20 million new cancer cases and 9.7 million deaths occurred in 2022. The expected number of persons who survived 5 years after a cancer diagnosis was 53.5 million. Furthermore, around one in every five persons develops cancer during their lifetime, with one in every nine men and one in every twelve women dying from the condition. Cancer patients frequently experience significant pain, and opioids are a key component of cancer pain therapy. As cancer rates increase internationally, so does the demand for effective pain management, driving the opioid industry expansion.

Opioids Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product type, application, and distribution channel.

Breakup by Product Type:

  • Codeine
  • Fentanyl
  • Methadone
  • Oxycodone
  • Morphine
  • Hydrocodone

Oxycodone accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product type. This includes codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. According to the report, oxycodone represented the largest segment.

According to the opioids market statistics, oxycodone has emerged as a dominant product type owing to its potent pain-relieving properties, which make it highly effective in managing severe pain, including post-operative and cancer-related pain. Physicians often prescribe oxycodone when other pain management options prove insufficient. Moreover, the pharmaceutical industry has invested significantly in the development of extended-release formulations of oxycodone, offering prolonged pain relief with fewer dosing intervals. Additionally, oxycodone's versatility allows for various administration routes, including oral tablets, capsules, and intravenous formulations, catering to diverse patient needs, which, in turn, is propelling its adoption.

Breakup by Application:

  • Pain Management
  • Cough Treatment
  • Diarrhea Treatment
  • Others

Pain management holds the largest share of the industry

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes pain management, cough treatment, diarrhea treatment, and others. According to the report, pain management accounted for the largest market share.

Based on the opioid market trends, pain management accounted for the largest market share. Opioid's fundamental role in the healthcare sector and the increasing recognition of the importance of effectively addressing pain is fueling its adoption in pain management applications. Pain refers to a pervasive and complex medical issue affecting millions of individuals worldwide, and opioids are considered a crucial component in managing moderate to severe pain, especially in acute and chronic pain conditions, post-surgical recovery, and cancer-related pain. The sheer prevalence of pain-related conditions owing to the burgeoning geriatric population and the rising incidence of cancer diagnoses, thereby creating a sustained demand for effective pain relief methods, is bolstering the opioids market share.

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, drug stores, online stores, and others.

According to the opioids market overview, hospital pharmacies represent a critical distribution channel as these settings are the first encounters of opioid prescriptions for patients, especially after surgeries or for acute pain management. They ensure controlled distribution and use, providing a direct link between the prescription and administration of opioids under medical supervision.

As per the opioids market analysis, retail pharmacies serve as the most accessible point for patients to fill opioid prescriptions for chronic pain management. They cater to the ongoing needs of patients outside the hospital setting, facilitating the continuity of care prescribed by healthcare providers. Retail pharmacies offer widespread availability, convenience, and, in some regions, counseling services to ensure safe use, boosting the opioid market revenue.

According to the opioids market report, drug stores offer a broader shopping experience with a particular focus on health. They provide a convenient option for patients to access their medications along with other healthcare products. The role of drug stores in the opioid industry underscores the balance between accessibility to necessary medications and the responsibility to limit access to prescription drugs to prevent abuse.

Online pharmacies represent a growing segment in the opioid market, offering patients convenience and lower prices for their medications. Moreover, rapid advancements in digital health technologies and changing consumer behaviors are favoring the shift toward online shopping. Along with this, online pharmacies increase access to pain management solutions in underserved or rural areas.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest opioids market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for opioids.

As per the opioids market outlook, The North American region dominated the market share due to several factors, including a high prevalence of chronic pain conditions, such as back pain and osteoarthritis, an aging population, and the widespread use of opioids in pain management. In addition to this, improved healthcare infrastructure and increased awareness of pain management options have led to higher opioid prescription rates, positively impacting the opioid market demand. Moreover, specialized addiction treatment centers and pharmacies have emerged as distribution channels, addressing the demand for these medications. Furthermore, evolving regulations and prescribing practices, influenced by stricter guidelines and prescription monitoring programs, are influencing the opioid market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the opioids industry include Boehringer Ingelheim International GmbH, Hikma Pharmaceuticals PLC, Mallinckrodt plc, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • According to recent research that analyzes the opioid market's recent developments, it has been found that leading pharmaceutical companies are investing heavily in research and development (R&D) to develop innovative opioid formulations. These efforts focus on creating opioids with improved safety profiles, reduced potential for abuse, and enhanced efficacy in pain management. The goal is to provide healthcare professionals with more effective and safer treatment options. Moreover, opioid market companies are closely monitoring and complying with evolving regulations and guidelines related to opioid prescribing, distribution, and usage. They are working to ensure that their products meet the highest safety and quality standards while adhering to stringent regulatory requirements. All these efforts are shaping the opioids market's recent price and opportunities.

Opioids Market News:

  • In June 2021, the U.S. Food and Drug Administration (FDA) accepted and granted priority review designation to new drug application (NDA) submitted by Purdue Pharma L.P. for nalmefene hydrochloride injection. The injectable is an opioid antagonist that is designed to reverse opioid overdose.
  • In February 2024, Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc., announced that it has reached an agreement in principle to resolve the several opioid related cases brought against the company by U.S. states, their subdivisions, and tribal nations. These cases relate to the manufacture and sales of prescription opioid medications. Hikma agreed to pay up to $115 million in cash and $35 million in donations of Hikma's naloxone, an opioid antagonist that is used to reverse the effects of opioid overdose.

Key Questions Answered in This Report:

  • How has the global opioids market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global opioids market?
  • What is the impact of each driver, restraint, and opportunity on the global opioids market?
  • What are the key regional markets?
  • Which countries represent the most attractive opioids market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the opioids market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the opioids market?
  • What is the breakup of the market based on the distribution channel?
  • Which is the most attractive distribution channel in the opioids market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global opioids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Opioids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Codeine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fentanyl
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Methadone
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Oxycodone
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Morphine
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hydrocodone
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cough Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hikma Pharmaceuticals PLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Mallinckrodt plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Pfizer Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Purdue Pharma L.P.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sanofi S.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sun Pharmaceutical Industries Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis